Archive for the ‘Pharma Industry / Biotech Industry’ Category
Sunday, August 3rd, 2008
Nventa Biopharmaceuticals Corporation (TSX: NVN) announced that it has completed analysis of immunological data from all four cohorts of its Phase 1 clinical trial for HspE7, its lead product candidate. HspE7 is a therapeutic treatment for patients with cervical intraepithelial neoplasia, or CIN, a precursor to cervical cancer. The primary ...
Posted in Pharma Industry / Biotech Industry | No Comments »
Sunday, August 3rd, 2008
The European Committee for Human Medicinal Products (CHMP) has confirmed that the presence of an impurity called ethyl methanesulfonate (EMS) in Roche's Viracept (nelfinavir mesylate) did not increase patients' risk of developing cancer. The discovery of the EMS impurity in some batches of nelfinavir led to a global recall of ...
Posted in Pharma Industry / Biotech Industry | No Comments »
Saturday, August 2nd, 2008
Thermo Fisher Scientific Inc., the world leader in serving science, announced the success of its liquid chromatography tandem mass spectrometry (LC-MS/MS) solution at Ameritox, a leading provider of forensic and specialty toxicology laboratory services. The Thermo Scientific TSQ Quantum Access triple ...
Posted in Pharma Industry / Biotech Industry | No Comments »
Friday, August 1st, 2008
Representatives of the U.S. Food and Drug Administration and the U.S. Marshals Service today seized $24.2 million worth of unapproved new drugs from KV Pharmaceutical Company of St. Louis, Mo. Agents acted after United States Attorney Catherine L. Hanaway filed a civil forfeiture suit and obtained a warrant to seize ...
Posted in Pharma Industry / Biotech Industry | No Comments »
Thursday, July 31st, 2008
GSK UK has announced that from 1st November 2008 it will partner with two of its current logistics service providers, AAH Pharmaceuticals Ltd and UniChem Ltd, to deliver its prescription medicines to customers in the UK.The NPA's Board will discuss this development at its meeting today.NPA chief executive, John Turk, ...
Posted in Pharma Industry / Biotech Industry | No Comments »
Thursday, July 31st, 2008
The European Forum for Industrial Biotechnology 2008 (EFIB2008) will take place from 15 to 17 September in Brussels, Belgium. Organised by EuropaBio (the European Association for Bioindustries) and IntertechPira, the event will feature two workshops, networking sessions and a two-day forum with approximately 30 leading speakers from biotech research, academia ...
Posted in Pharma Industry / Biotech Industry | No Comments »
Wednesday, July 30th, 2008
Titan Pharmaceuticals, Inc. (AMEX:TTP) announced that Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) has received a not approvable letter for iloperidone, an investigational atypical antipsychotic for the treatment of schizophrenia, from the U.S. Food and Drug Administration (FDA). Vanda, the sub-licensee for iloperidone, is responsible for the development and commercialization of this product. ...
Posted in Pharma Industry / Biotech Industry | No Comments »
Wednesday, July 30th, 2008
FDA takes an average of seven months to issue warnings to pharmaceutical companies that market medications for off-label uses, and those companies take an average of four months to address the violations, according to a draft report compiled by the Government Accountability Office, the AP/Minneapolis Star Tribune reports. The ...
Posted in Pharma Industry / Biotech Industry | No Comments »
Wednesday, July 30th, 2008
Hundreds of biotechnology start-ups will be encouraged to utilize an incentive for capital investments as a result of a provision included in the Housing Bill passed by the U.S. House of Representatives last night by a vote of 272 - 152. "Many biotech companies whose products have not ...
Posted in Pharma Industry / Biotech Industry | No Comments »
Tuesday, July 29th, 2008
Lawmakers on Thursday during a hearing of the Joint Economic Committee criticized pharmaceutical companies for large price increases for brand-name medications for rare diseases, CQ HealthBeat reports. According to recent analyses conducted by AARP and the PRIME Institute at the University of Minnesota, brand-name medications often undergo price increases ...
Posted in Pharma Industry / Biotech Industry | No Comments »
Tuesday, July 29th, 2008
The Russian-CIS pharmaceutical market is exploding. PriceWaterhouseCooper records suggest that the Russian Pharmaceutical market is growing by over 1/3 every year. This growth creates new challenges. How do you make your Sales Force more effective and not just larger to ensure long-term success? The Sales Force Effectiveness Summit, October ...
Posted in Pharma Industry / Biotech Industry | No Comments »
Tuesday, July 29th, 2008
Genentech Forms Special Committee of Independent Directors to Review Roche Proposal Genentech, Inc. (NYSE:DNA) announced today that it has formed a special committee of its Board of Directors, composed of the company's three independent directors, to assess the proposal from Roche to acquire all of the outstanding shares of Genentech ...
Posted in Pharma Industry / Biotech Industry | No Comments »
Saturday, July 26th, 2008
As a group, autoimmune diseases remain one of the most refractory and difficult-to-treat segments of healthcare therapeutics. The underlying genetics of the immune response and the complexities they foster among individual patients make this one of the most challenging areas in all of life science. Until recently, autoimmune disease patients ...
Posted in Pharma Industry / Biotech Industry | No Comments »
Friday, July 25th, 2008
The European Committee for Human Medicinal Products (CHMP) has confirmed that the presence of an impurity called ethyl methanesulfonate (EMS) in Roche's Viracept (nelfinavir mesylate) did not increase patients' risk of developing cancer. The discovery of the EMS impurity in some batches of nelfinavir led to a global recall of ...
Posted in Pharma Industry / Biotech Industry | No Comments »
Friday, July 25th, 2008
The Scientific business of Thomson Reuters has announced the availability of the newly published CMR International 2008 Pharmaceutical R&D Factbook, an indispensable reference and business planning tool for decision makers in pharmaceutical R&D, corporate finance, business strategy, marketing planning and corporate communications. This year's Factbook offers a comprehensive and ...
Posted in Pharma Industry / Biotech Industry | No Comments »
